Big Pharma Tells Justices To Keep Assignor Estoppel
The drug industry's top lobbying group has warned the U.S. Supreme Court that if it grants a surgical device company's bid to abolish the doctrine of assignor estoppel, which bars those...To view the full article, register now.
Already a subscriber? Click here to view full article